2 September 2010

Maverick Entertainment

NO RECOMMENDATION

24/04/2002

Maverick Entertainment looks set for a busy 2002. Last year the media rights company reported a £225,561 (£151,750) loss on £330,889 (£94,821) of revenues. But having launched a DVD version of Transformers The Movie late in 2001, this year's sales figures should be considerably higher. The launch of the DVD coincided with toy manufacturer Hasbro's decision to re-launch a range of Transformers toys. Managing director Mike Diprose explains the significance, stating that '12 months ago we were selling the video for £4.99. We can now sell the DVD for £15.99'. In addition, Maverick holds IP rights over the likes of Fuzzy Felt, GI Joe, My Little Pony and the Moomins, yet the highest hopes are reserved for Snailsbury Tales, an original cartoon it is producing for the BBC. The series will begin screening on digital TV this summer and should reach terrestrial screens by September. As well as its agreement with the BBC, Maverick has signed a seven-year deal with Australian state TV channel ABC - granting it publishing, merchandising and licensing rights Down-Under. A range of toys should hit the shops in early 2003. An interesting, if high-risk, punt for penny share devotees.

Sector: Media

Companies: Maverick Entertainment

Market cap: £4.3m

PE Forecast: n/a

Share price: 3p

Subscribe today


More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.

Subscribe today and save 50%

VCT Report 2010

VCT Report 2010 uncovers the money available

for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted

company.

Order VCT Report 2010 today using this online form

Cash Shells Directory 2010

A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.

Coverage of AIM, techMARK and PLUS Markets

Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.

Take control of your investments

A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.

The Financial Times Guide to Personal Tax

is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.

The AIM Guide Spring 2010

The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).

A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!

Share recommendations and small-cap stock picks

Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.

Popular Recommendations

Latest Recommendations

Delcam 01/09/2010

Delcam, the international seller of CAD/CAM software to the engineering, aerospace and healthcare sectors among others, is a cash-generative small-cap seeing recovery in its markets.

Antisoma 01/09/2010

Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.

GW Pharmaceuticals 31/08/2010

GW Pharmaceuticals has won approval from Health Canada for its cannabis-based Sativex product to treat spasticity caused by Multiple Sclerosis.

More Recommendations

Sectors

Vitesse Media Events